JANE STREET GROUP, LLC

Position in SCPX — Scorpius Holdings, Inc.

CIK 1595888 NEW YORK, NY

Back to SCPX Full portfolio

Position in SCPX

as of Jun 30, 2025 · filed Aug 14, 2025 Compact

Position Value

$521

-$12,900 QoQ

Shares Held

11,113

-63.5% QoQ

Ownership

0.018%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

of 2 holders

Holding Since

Jun 2021

6 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in SCPX Over Time

Shares Held

Position Value (USD)

Derivatives in SCPX

reported options exposure · as of Dec 31, 2021

CallValue

CallShares

PutValue

$95,152

PutShares

31,300

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JANE STREET GROUP, LLC holds $1,363,981,840 across 291 Biotechnology names.

#	Ticker	Company	Shares	Value (USD)
1	BBIO	BridgeBio Pharma, Inc.	2,934,193	$218,538,693
2	MDGL	Madrigal Pharmaceuticals, Inc.	191,541	$102,847,939
3	AXSM	Axsome Therapeutics, Inc.	403,995	$98,885,855
4	TGTX	Tg Therapeutics, Inc.	1,752,646	$96,290,370
5	EXEL	Exelixis, Inc.	1,402,438	$76,306,651
6	QURE	uniQure N.V.	1,610,483	$74,178,846
7	HALO	Halozyme Therapeutics, Inc.	694,684	$54,372,915
8	TVTX	Travere Therapeutics, Inc.	938,699	$53,327,489

All Filings in SCPX

Export CSV

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2025-06-30	$521	11,113	-63.5%	Shares	Defined	2025-08-14
2023-12-31	$13,421	30,483	+92.5%	Shares	Defined	2024-02-15
2022-12-31	$12,747	15,833	-10.9%	Shares	Defined	2023-02-15
2022-03-31	$54,400	17,778	-25.7%	Shares	Defined	2022-05-17
2021-12-31	$72,761	23,935	—	Shares	Defined	2022-02-15
2021-12-31	$95,152	31,300	+46.9%	Put	Defined	2022-02-15
2021-06-30	$146,714	21,800	—	Call	Defined	2021-08-16
2021-06-30	$143,349	21,300	—	Put	Defined	2021-08-16
No filing history on record for this holder in this stock.